F&P Healthcare raises full-year guidance
Another positive update from NZ respiratory products group, Fisher & Paykel Healthcare (ASX:FPH), on Friday.
Read More
Fisher & Paykel Healthcare Corporation Limited
At Fisher & Paykel Healthcare, we fully understand the life-changing impact that can result from delivering inspired and world-leading healthcare solutions.
After all, we changed the way the world delivers respiratory humidification to critically ill patients in hospital, and were the first organisation in the world to make a humidifier specifically for use in the treatment of patients with obstructive sleep apnea.
Today, through an unrivalled commitment to innovation; to doing the right thing; and doing what is best for the patient, we continue to inspire world-leading healthcare solutions.
Our team of self-motivated, empathetic and committed individuals is our strength. It is this team; our originality; the value we place on relationships; our international perspective; and the utmost care for all patients, customers, suppliers, shareholders, as well as the environment, that will ultimately ensure we will be the healthcare company of choice.
Videos
Videos coming soon for Fisher & Paykel Healthcare Corporation Limited.
News
Fisher & Paykel Healthcare reports improved financials
A slightly higher dividend was announced for its 2023-24 financial year, along with expectations for a slightly better result in 2024-25, by New Zealand-based Fisher & Paykel Healthcare Corporation (ASX:FPH) on Wednesday.
Read More
FPH upgrades earnings guidance driven by currency rate movements
Good news and bad news on Friday from NZ-based Fisher and Paykel Healthcare.
Read More
Fisher & Paykel Healthcare raises dividend
New Zealand-based Fisher & Paykel Healthcare Corporation has increased its interim dividend from 17.5 NZ cents to 18 NZ cents for the six months ending September 30, following a robust performance with a 16% rise in revenue and a 12% increase in after-tax earnings.
Read More
Fisher & Paykel continues to excel with post-pandemic strategies
Fisher & Paykel Healthcare Corporation looks on track to make guidance for the six months to September and the full financial year ending March 2024.
Read More
Breakfast Bites: FPH, AUC
Let's start the new week with a couple quick stories we couldn't fit into our bumper weekend edition, involving Fisher & Paykel Healthcare and Ausgold.
Read More
Impeccable Bill of Health for Fisher & Paykel
Shares in Fisher and Paykel Healthcare leapt 14% yesterday after the company produced a forecast for a second half improvement on what was a solid first six-months.
Read More
Sleepless Nights for Rivals after Philips Warning
Concerns for Resmed and Fisher and Paykel Healthcare after a surprise profit warning from Philips, their big Dutch rival in the sleep and respiratory sectors, saw its share price hit 10-year lows.
Read More
FPH – Citi rates the stock as Buy
Buy rating retained. Target price falls to NZ$24 from NZ$25.75.
Read More
Industrials Intel: CGC, FPH, ALQ
Things were also busy across in the ASX Industrials sector. Here's some news released during the Wednesday session by Costa Group, Fisher & Paykel Healthcare and ALS Ltd.
Read More
